Advertisement
Screener

IMMUNITYBIO, INC. (IBRX) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

IMMUNITYBIO, INC. Cash Flow Breakdown

Cash flow breakdown shows where IMMUNITYBIO, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $304.94M went out.
  • Fiscal year ended 2025-12-31: from investing, $149.80M went out.
  • Fiscal year ended 2025-12-31: from financing, $400.24M came in.
  • Fiscal year ended 2025-12-31: change in cash, $54.48M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksDebt paid backStaff share taxNew shares soldNot split outChange in cash
2025-12-31-$304.94M-$149.80M-$1.13M-$2.27M$403.64M*-$54.48M
2024-12-31-$391.24M-$12.25M$0.00-$5.46M$287.10M*-$121.88M
2023-12-31-$366.76M-$30.47M$0.00-$3.44M$294.00K$561.49M*$160.82M
2022-12-31-$337.51M$27.30M-$616.00K$60.43M$173.80M*-$76.31M
2021-12-31-$274.42M-$84.89M$0.00-$4.06M$164.53M$344.98M*$146.19M
2020-12-31-$171.72M-$19.81M$0.00-$503.00K$86.30M$64.88M*-$40.89M
2019-12-31-$152.11M$18.55M-$2.50M-$127.00K$30.00M$86.91M*-$19.30M
2018-12-31-$63.38M$57.10M-$228.00K-$123.00K$0.00-$7.05M
2017-12-31-$48.78M$99.55M-$15.23M-$1.04M-$18.72M*$15.79M
2016-12-31-$38.59M-$113.67M-$15.85M-$1.11M*$0.00-$167.82M
2015-12-31-$25.30M-$175.22M-$4.80M-$2.42M$878.00K$323.67M*$116.80M
2014-12-31-$5.42M-$235.00K$0.00$0.00$1.16M$63.24M*$58.75M
2013-12-31-$668.00K-$3.00K$230.00K$675.00K*$234.00K

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksDebt paid backStaff share taxNew shares soldNot split outChange in cash
2026-06-30-$66.49M*-$107.47M*-$886.00K*-$319.00K*$45.65M*
2026-03-31-$75.36M-$31.65M-$868.00K-$6.99M$971.00K$230.82M*$117.04M
2025-12-31-$70.38M*$43.57M*-$590.00K*$55.48M*
2025-09-30-$68.91M*-$181.36M*-$151.00K*$173.67M*
2025-06-30-$79.75M*-$16.14M*$0.00*-$322.00K*$173.13M*
2025-03-31-$85.91M$4.13M$0.00-$1.20M$220.00K-$82.77M
2024-12-31-$85.14M*$9.83M*-$803.00K*$107.73M*
2024-09-30-$98.76M*$65.03M*-$299.00K*$15.88M*
2024-06-30-$100.35M*-$51.49M*-$496.00K*$149.39M*
2024-03-31-$106.98M-$35.62M-$3.87M$0.00$14.09M*-$132.42M
2023-12-31-$115.27M*$2.25M*-$1.56M*$1.00K*$202.10M*
2023-09-30-$87.40M*-$15.63M*-$1.46M*$32.00K*$238.93M*
2023-06-30-$79.77M*-$8.60M*-$60.00K*$135.00K*$43.34M*
2023-03-31-$84.31M-$8.48M-$357.00K$47.29M$29.96M*-$16.16M
2022-12-31-$90.73M*-$18.89M*-$219.00K*$60.43M*$49.73M*
2022-09-30-$80.60M*-$1.17M*-$10.00K*$0.00*$124.00M*
2022-06-30-$91.25M*$116.67M*-$15.00K*$0.00*
2022-03-31-$74.93M-$69.31M-$372.00K$0.00-$144.72M
2021-12-31-$71.64M*-$137.80M*-$480.00K*$27.58M*$298.85M*
2021-09-30-$72.72M*$10.58M*-$960.00K*$41.92M*$1.69M*
2021-06-30-$69.59M*$10.49M*$0.00*$3.31M*$95.03M*
2021-03-31-$60.47M$31.84M-$2.62M$1.12M$40.00M*$9.76M
2020-12-31-$57.60M*$7.54M*$0.00*-$18.00K*$0.00*
2020-09-30-$36.99M*-$56.63M*$0.00*-$322.00K*-$514.00K*$64.05M*
2020-06-30-$46.02M*$15.27M*-$40.00K*$600.00K$86.78M*
2020-03-31-$31.11M$13.99M-$123.00K$0.00-$17.15M
2019-12-31-$105.63M*$9.26M*-$2.00M*-$61.00K*$30.00M*$47.69M*
2019-09-30-$16.57M*$17.37M*$0.00*-$40.00K*$0.00*
2019-06-30-$16.83M*$11.38M*$0.00*-$501.00K*
2019-03-31-$13.08M-$19.46M-$26.00K$39.22M*$6.66M
2018-12-31-$14.03M*$15.91M*-$228.00K*$0.00*
2018-09-30-$17.57M*$16.87M*$0.00*$0.00*
2018-06-30-$16.27M*$21.39M*$0.00*-$80.00K*
2018-03-31-$15.51M$2.92M$0.00-$43.00K-$12.68M
2017-12-31-$13.64M*$19.73M*-$2.77M*-$330.00K*$2.95M*
2017-09-30-$10.13M*$6.96M*$0.00*$0.00*-$14.95M*-$18.12M*
2017-06-30-$14.95M*$56.82M*-$11.41M*-$159.00K*-$4.86M*$25.44M*
2017-03-31-$10.06M$16.04M-$1.05M*-$550.00K$5.51M
2016-12-31-$10.75M*-$8.46M*-$3.95M*-$514.00K*-$23.32M*
2016-09-30-$10.68M*$6.86M*-$2.57M*-$592.00K*-$6.82M*
2016-06-30-$8.30M*-$10.15M*-$6.77M*$0.00*-$25.03M*
2016-03-31-$8.86M-$101.91M-$2.55M$0.00$660.00K*-$112.66M
2015-12-31-$10.94M*-$172.12M*$0.00*$0.00*$35.00K*-$182.71M*
2015-09-30-$4.20M*-$651.00K*$0.00*$75.00K*$243.00M*$238.18M*
2015-06-30-$2.79M*-$597.00K*$73.97M*$70.58M*
2015-03-31-$7.37M-$1.86M-$9.25M
2014-12-31-$2.57M*-$30.00K*$1.09M*$57.44M*$55.92M*
2014-09-30-$753.00K*-$188.00K*-$812.00K*
2014-06-30-$2.05M*-$19.00K*
2014-03-31-$38.00K$2.00K

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
REPLIGEN CORP (RGEN)United States$10.755B185.31
Immunovant, Inc. (IMVT)United States$7.028B-14.78
BIO-TECHNE Corp (TECH)United States$11.379B74.68
Twist Bioscience Corp (TWST)United States$11.540B-47.21
CG Oncology, Inc. (CGON)United States$6.095B-27.95
Scholar Rock Holding Corp (SRRK)United States$5.920B-16.37
CRISPR Therapeutics AG (CRSP)$5.390B-11.68